|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
1996-4-12
|
|
pubmed:abstractText |
Drugs that inhibit angiotensin-converting enzyme slow the progression of renal insufficiency in patients with diabetic neuropathy. Whether these drugs have a similar action in patients with other renal diseases is not known. We conducted a study to determine the effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of renal insufficiency in patients with various underlying renal diseases.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
11
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
939-45
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8596594-Adult,
pubmed-meshheading:8596594-Aged,
pubmed-meshheading:8596594-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:8596594-Benzazepines,
pubmed-meshheading:8596594-Blood Pressure,
pubmed-meshheading:8596594-Disease Progression,
pubmed-meshheading:8596594-Double-Blind Method,
pubmed-meshheading:8596594-Female,
pubmed-meshheading:8596594-Humans,
pubmed-meshheading:8596594-Kidney Diseases,
pubmed-meshheading:8596594-Kidney Failure, Chronic,
pubmed-meshheading:8596594-Male,
pubmed-meshheading:8596594-Middle Aged,
pubmed-meshheading:8596594-Severity of Illness Index,
pubmed-meshheading:8596594-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
|
|
pubmed:affiliation |
Divisione di Nefrologia, Ospedale Civile, Verona, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
